Texte intégral
EB13.R51 Approval of Yellow-Fever Vaccine The Executive Board
1. ENDORSES the action taken by the Director-General in according provisional approval, for the issue of international certificates of vaccination and revaccination against yellow fever, to the yellow-fever vaccine manufactured by the National Drug Company, Swiftwater, Pennsylvania (United States of America) ; and
2. ACCORDS approval to this vaccine.
Handb. Res., 2nd ed., 1.8.3.2 (Twenty-sixth meeting, 1 February 1954)
Documents relatifs
Noting that the United Nations General Assembly, in resolution 3371 (XXX), established an assessment rate of 0.08% for 1974 ， 1975 and 1976 for Bangladesh, following its admission
PAYS TRIBUTE to the memory of Professor Jacques Parisot and expresses its gratitude to Madame Jacques..
Despite the good vaccination coverage against YF in the general population of French Gui- ana resulting from the compulsory nature of YF vaccination for residents and travelers,
YF vaccination activities were collated from various sources on (i) historical large-scale vaccination activities 1940–1960s [11], (ii) outbreak response campaigns since 1970
Alternative use (repurposing) of the meningitis vaccine stockpile doses nearing expiry is to be reviewed by the Gavi Board in December 2020, and it is likely that a new conjugate
Specific or support messages – such as safety, mode of administration, mode of transmission and the vaccination calendar – should be administered through communication channels
The power of our experiment to detect a statistically significant effect of manipulating the maternal immune response on each of the six offspring fitness traits: survival,
- the working group "test methods" which has to define the conditions in which fireworks must be examined, both for type approval tests and for quality control tests. -
